Reviews
Average rating: 3/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 3.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
Alphanate is used less frequently for von Willebrand disease compared to products like Humate-P or Wilate because it has lower and more variable VWF activity, and its VWF:FVIII ratio is generally lower. This means it may require higher dosing or closer monitoring to achieve adequate VWF levels. Additionally, it is not FDA-approved specifically for VWD in the U.S. (only for hemophilia A with VWF activity as a secondary indication), which limits its preferred use in clinical guidelines.
0